Yidu Tech AI (YIDU) Stock Price – 531m on Friday
Yidu Tech AI Hong Friday 531m stock price has surged by 53% since its initial public offering last May, and investors are starting to feel optimistic. The stock has forecasts of 43% revenue growth over the next four years. Nevertheless, the looming global recession will dampen the stock’s momentum. Meanwhile, the company faces the threat of stricter Covid control measures in case of more pandemic flareups.
Also Read: movies wood
Stock price: 531m yuan
Yidu Tech AI Hong Friday 531m is a smart healthcare company in China. Its products and services cover analytics-driven clinical development, real-world evidence-based research, digital commercialization, insurance technology solutions, and medical device sales. As of March 31, Yidu had processed more than 2.6 billion healthcare records from 600 million patients. Its customers include pharmaceutical companies, medical institutions, and insurance brokerage companies.
Yidu’s IPO was very popular among retail investors, as demand for its shares exceeded supply by nearly one-third. It was the third highest-subscription rate among retail investors in the past 12 months. The IPO reflected a growing appetite for IPOs among retail buyers. In particular, health care and tech sectors became a hot commodity, and biotech IPOs were very sought-after in Hong Kong. In some cases, small-time traders crowded out institutional investors.
Yidu Tech AI Hong Friday 531m (formerly known as Happy Life Tech) is one of the new generation of big data medical companies in China. It aims to improve efficiency and access to health care in China. The aging population in China is creating a need for quality healthcare. This has led pharmaceutical and medical enterprises to increasingly turn to big data services. While the industry is still in its infancy in China, it has huge development potential. According to Frost & Sullivan, China’s healthcare intelligence market is estimated to grow to over 1.1 trillion yuan by 2030.
Forecast: 43% revenue growth from 2021 to 2026
Yidu’s revenue is expected to grow 43 percent over the next five years, according to a new forecast by Goldman Sachs. The company is known for its strict data privacy policies, which are more stringent than those of its competitors. Goldman Sachs also expects losses to narrow in the second half of 2022 and move its breakeven forecast to 2024.
Yidu Tech AI Hong Friday 531m is part of a new generation of big data medical companies in China. The company aims to boost the efficiency of the healthcare system in the country. China’s population is aging and the country is trying to provide better access to quality health care for all citizens. As a result, medical and pharmaceutical enterprises are turning to big data analytics to improve patient care. This industry is relatively new in China, but it has huge growth potential. According to Frost & Sullivan, the healthcare intelligence industry in China is expected to be worth over 1.1 trillion yuan by 2030.
AI-related spending in China will surpass US$15 billion by 2026. According to the report, AI software is expected to grow at a CAGR of 33.1% over the next five years.
The company’s net loss has narrowed to 762 million yuan from 3.7 billion yuan in the previous year. Its full-year revenue growth has decreased from 62.3% in the first half of the year to a 3.7% CAGR. The health management platform and solutions segment showed strong growth, with 624.6% in the first half of the year and 68.3% for the full year.
Outlook: Slow growth in next fiscal year
Yidu Tech AI Hong Friday 531m (YIDU) is a big data medical company in China that focuses on increasing efficiency in the healthcare system. China’s aging population and efforts to improve access to quality healthcare are driving a demand for big data and analytics services. While the industry is relatively young, the potential for growth is enormous. According to Frost & Sullivan, the market for healthcare intelligence in China will be worth more than 1.1 trillion yuan by 2030.
Yidu Tech AI Hong Friday 531m has made investments in data security and privacy. It is one of three healthcare technology companies in China certified by the CAICT for secure multi-party computing and federated learning capabilities. It also has more than a thousand registered patents and five hundred and fifty-one granted patents. Its patent portfolio includes a total of 127,060 patents, including 114 issued in the past year.
